Cagrilintide
5 mgTitration schedule
Full ramp to 4.5 mg weekly - higher studied targetInvestigational study-dose framework - not an approved prescribing schedule.
| Stage | Weekly amount | U-100 draw |
|---|---|---|
| Weeks 1-4 | 0.3 mg once weekly | 12 units |
| Weeks 5-8 | 0.6 mg once weekly | 24 units |
| Weeks 9-12 | 1.2 mg once weekly | 48 units |
| Weeks 13-16 | 2.4 mg once weekly | 96 units |
| Week 17+ | 4.5 mg once weekly - maintenance | 180 units |
Optional higher studied target; not an automatic required target.
A calculated dose above 100 units exceeds one 100-unit U-100 syringe at this concentration. Use an appropriate multi-draw plan and verify the full dose.
Escalation is not automatic. Hold the current dose longer when tolerability requires it. The 4.5 mg higher studied target is optional, not required.